OI
AMED

Oakbrook Investments’s Amedisys AMED Stock Holding History

Oakbrook Investments’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,300
Closed -$384K – 102
2019
Q4 		$384K Buy
2,300
+100
+5% +$14.9K 0.08% 396
2019
Q3 		$288K Buy
2,200
+100
+5% +$13K 0.02% 498
2019
Q2 		$255K Buy
+2,100
New +$249K 0.02% 522

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Oakbrook Investments's AMED Position: Q1 2020 in Review

Oakbrook Investments sold out of Amedisys (AMED) in Q1 2020, closing a stake of 2,300 shares — an estimated $384K sold.

Oakbrook Investments first reported a position in AMED in Q2 2019 and held it in 3 quarters. The position peaked at $384K in Q4 2019. 332 funds tracked by Wall St. Rank hold AMED as of Q1 2020.

  • Oakbrook Investments reported no remaining Amedisys position as of Q1 2020 after selling out during the quarter.
  • Oakbrook Investments sold 2,300 Amedisys shares in Q1 2020, an estimated $384K.
  • Oakbrook Investments first reported a position in Amedisys in Q2 2019 and held it in 3 quarters.
  • Oakbrook Investments's Amedisys position peaked at $384K in Q4 2019.
  • 332 funds tracked by Wall St. Rank held Amedisys as of Q1 2020.

Based on Oakbrook Investments's 13F filing for Q1 2020, filed 22 Apr 2020.